Skip to Content

Nano Curry

Encased curcumin could be a drug.
August 15, 2007

In recent years, laboratory and animal studies have suggested that curcumin–the pigment that gives the Indian curry spice turmeric its bright-yellow hue–could be useful for treating tumors, cystic fibrosis, and even Alzheimer’s disease. But curcumin is insoluble and not readily absorbed by the body, making it impractical as a drug.

The nanoparticles shown here have hydrophobic interiors that hold the curcumin and hydrophilic exteriors that make them more readily absorbed.

Now researchers at the Johns Hopkins University School of Medicine and the University of Delhi, in India, have invented ­curcumin-­carrying nanospheres that slip easily into the bloodstream. ­Anirban Maitra, an associate professor of pathology and oncology at Johns Hopkins, and his collaborators in Delhi used polymers to make particles about 50 nanometers in diameter. The nanoparticles (left) have hydrophobic interiors that hold the curcumin and hydrophilic exteriors that make them more readily absorbed. Once the particles are in the blood, the curcumin leaks out as the polymers slowly degrade. Maitra and colleagues are now planning animal studies.

Keep Reading

Most Popular

AGI is just chatter for now concept
AGI is just chatter for now concept

The hype around DeepMind’s new AI model misses what’s actually cool about it

Some worry that the chatter about these tools is doing the whole field a disservice.

Hoan Ton-That, CEO of Clearview AI
Hoan Ton-That, CEO of Clearview AI

The walls are closing in on Clearview AI

The controversial face recognition company was just fined $10 million for scraping UK faces from the web. That might not be the end of it.

Europe's AI Act concept
Europe's AI Act concept

A quick guide to the most important AI law you’ve never heard of

The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.